Squarepoint’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $456K | Buy |
48,422
+29,350
| +154% | +$276K | ﹤0.01% | 1958 |
|
|
2025
Q1 | $103K | Sell |
19,072
-21,442
| -53% | -$116K | ﹤0.01% | 2517 |
|
|
2024
Q4 | $302K | Buy |
40,514
+18,416
| +83% | +$137K | ﹤0.01% | 2186 |
|
|
2024
Q3 | $177K | Sell |
22,098
-24,358
| -52% | -$195K | ﹤0.01% | 2214 |
|
|
2024
Q2 | $404K | Sell |
46,456
-92,203
| -66% | -$802K | ﹤0.01% | 1824 |
|
|
2024
Q1 | $2.87M | Buy |
+138,659
| New | +$2.87M | ﹤0.01% | 913 |
|
|
2023
Q2 | – | Sell |
-65,786
| Closed | -$193K | – | 2514 |
|
|
2023
Q1 | $193K | Buy |
+65,786
| New | +$193K | ﹤0.01% | 1883 |
|
|
2022
Q1 | – | Sell |
-13,996
| Closed | -$171K | – | 2416 |
|
|
2021
Q4 | $171K | Buy |
+13,996
| New | +$171K | ﹤0.01% | 2153 |
|
|
2021
Q2 | – | Sell |
-14,327
| Closed | -$146K | – | 2739 |
|
|
2021
Q1 | $146K | Sell |
14,327
-10,455
| -42% | -$107K | ﹤0.01% | 2258 |
|
|
2020
Q4 | $163K | Sell |
24,782
-9,476
| -28% | -$62.3K | ﹤0.01% | 2214 |
|
|
2020
Q3 | $177K | Sell |
34,258
-2,618
| -7% | -$13.5K | ﹤0.01% | 1979 |
|
|
2020
Q2 | $279K | Buy |
36,876
+26,936
| +271% | +$204K | ﹤0.01% | 1599 |
|
|
2020
Q1 | $101K | Buy |
9,940
+8,600
| +642% | +$87.4K | ﹤0.01% | 1627 |
|
|
2019
Q4 | $21K | Buy |
+1,340
| New | +$21K | ﹤0.01% | 2331 |
|
|
2017
Q3 | – | Sell |
-5,860
| Closed | -$100K | – | 1665 |
|
|
2017
Q2 | $100K | Buy |
+5,860
| New | +$100K | ﹤0.01% | 1399 |
|
|
2017
Q1 | – | Sell |
-1,040
| Closed | -$18K | – | 1624 |
|
|
2016
Q4 | $18K | Buy |
+1,040
| New | +$18K | ﹤0.01% | 1729 |
|